Peter Hilgard
17Patents
6h-index
23Co-inventors
62Inventor score
Filing activity: Feb 22, 1985 → Nov 8, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5773032A | Long-acting injection suspensions and a process for their preparation | Human Necessities | 22 | Expired |
| US5663145A | Products for administering an initial high dose of Cetrorelix and producing a combination package for use when treating diseases | Human Necessities | 14 | Expired |
| US4716242A | Salts of oxazaphosphorine derivatives | Human Necessities | 8 | Expired |
| US6093704A | Use of dopamine receptor antagonists in palliative tumor therapy | Human Necessities | 7 | Expired |
| US6696428B2 | Use of dopamine receptor antagonists in palliative tumor therapy | Human Necessities | 6 | Expired |
| US6172050A | Phospholipid derivatives | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5219866A | Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparation | Chemistry; Metallurgy | 5 | Expired |
| US6903080B2 | Disease treatment with novel phospholipid derivatives | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6544551B1 | Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5238955A | Ethylene-substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkylethylenediamines | Chemistry; Metallurgy | 2 | Expired |
| US5194644A | Ethylene-substituted phenylalkylethylene-diamine-platinum (II or IV) derivatives and phenylalkylethylenediamines | Chemistry; Metallurgy | 2 | Expired |
| US5023335A | 1,2-bis (aminomethyl) cyclobutane-platinum complexes | Human Necessities | 2 | Expired |
| US5958906A | Phospholipid derivatives containing higher elements of the fifth main group | Chemistry; Metallurgy | 0 | Expired |
| US5637577A | Phospholipid derivatives containing higher elements of the fifth group | Chemistry; Metallurgy | 0 | Expired |
| US6479472B1 | Methods of using therapeutic phospholipid derivatives | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5449798A | Phospholipid derivatives containing higher elements of the fifth group | Chemistry; Metallurgy | 0 | Expired |
| US6576624B1 | Use of dopamine receptor antagonists in palliative tumor therapy | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.